Correspondent/Executive Director/CEO: Patricia Dahl, CEBT
Medical Director: Michelle Rhee, MD
Date established: December 1944
Provides ocular tissue for penetrating keratoplasty, endothelial keratoplasty, keratolimbal allografts, lamellar grafts and scleral grafts.